Dow Up 0.64% Nasdaq Up 0.68%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.27 0.37(9.49%) Sep 18, 4:00PM EDT
Prev Close:3.90
Open:3.93
Bid:4.19 x 1000
Ask:4.38 x 4900
1y Target Est:7.00
Beta:-2.28
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:3.90 - 4.34
52wk Range:3.82 - 7.97
Volume:10,975,760
Avg Vol (3m):4,900,040
Market Cap:938.70M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNAUp 9.49%938.70M
GSK113.59B
OREX599.19M
RHHBY257.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback